Stress enchocardiography

Current Pharmaceutical Design

Volumn 11, Issue 17, 2005, Pages 2137-2149

  Picano, E ^b   Pasanisi, E ^b   Venneri, L ^b   Agrusta, M ^a   Mottola, G ^a   Sicari, R ^b  

^a Clinica Cardiologica Montevergine   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE;

ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIZZINESS; DOPPLER ECHOCARDIOGRAPHY; DOSE RESPONSE; DRUG ACTIVITY; DRUG SAFETY; EXERCISE TEST; HEADACHE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEART VENTRICLE WALL MOTION; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; LUNG EDEMA; MICROANGIOPATHY; NAUSEA; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; ECONOMICS; METHODOLOGY;

CORONARY ARTERIOSCLEROSIS; ECHOCARDIOGRAPHY, STRESS; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 21044432387     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612054367454     Document Type: Review

References (49)

1. Picano E. Stress Echocardiography. 4th edition Edited by E Picano. Heidelberg: Springer-Verlag, 2003.
2. Picano E. Dipyridamole-echocardiography test: the historical background and the physiologic basis. Eur Heart J 1989; 10: 365-376.
3. Picano E. Stress echocardiography: from pathophysiological toy to diagnostic tool. Point of view. Circulation 1992; 85: 1604-1612.
4. Picano E, Palinkas A, Amyot R. Diagnosis of myocardial ischemia in hypertensive patients. J Hypertens 2001; 19: 1177-83.
5. Pingitore A, Picano E, Colosso MQ, Reisenhofer B, Gigli G, Lucarini AR, et al. The atropine factor in pharmacological stress echocardiography. J Am Coll Cardiol 1996, 27: 1164 -1170.
6. Picano E, Bedetti G, Varga A, Cseh E. The comparable diagnostic accuracies of dobutamine-stress and d ipyridamole-stress echocardiographics: a meta-analysis. Coron Artery Dis 2000; 11: 151-9.
7. Armstrong WF, Pellikka PA, Ryan T, Crouse L, Zoghbi WA. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 1998; 11: 97-104.
8. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. American College of Cardiology; American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003; 41: 159-68.
9. Lee TH, Boucher CA. Clinical practice. Noninvasive tests in patients with stable coronary artery disease. N Engl J Med 2001; 344: 1840-5.
10. Picano E, Lattanzi F, Orlandini A, Marini C, L'Abbate A. Stress echocardiography and the human factor: the importance of being expert. J Am Coll Cardiol 1991; 17: 666-669.
11. Varga A, Picano E, Dodi C, Barbieri A, Pratali L, Gaddi O. Madness and method in stress echo reading. Eur Heart J 1999; 20: 1271-1275.
12. Lu C, Picano E, Pingitore A, Sicari R, Tongiani R, Baratto M, et al. Complex artery coronary lesion morphology influences results of stress echocardiography. Circulation 1995; 91: 1669-1675.
13. Beleslin BD, Ostojic M, Djordjevic-Dikic A, Babic R, Nedeljkovic M, Stankovic G, et al. Integrated evaluation of relation between coronary lesion features and stress echocardiography results: the importance of coronary lesion morphology. J Am Coll Cardiol 1999; 33: 717-26.
14. Gliozheni E, Picano E, Bernardino L, Pingitore A, Sicari R, Marzilli M. Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing. Am J Cardiol 1996: 78: 1419-1424.
15. Picano E, Severi S, Michelassi C, Lattanzi F, Masini M, Orsini E, et al. Prognostic importance of dipyridamole echocardiography test in coronary artery disease. Circulation 1989; 80: 450- 457.
16. Picano E, Landi P, Bolognese L, Chiaranda G, Chiarella F, Seveso G, et al. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group. Am J Med 1993; 95: 608-18.
17. Severi S, Picano E, Michelassi C, Lattanzi F, Landi P, Distante A, et al. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography. Circulation 1994; 89: 1160-73.
18. Poldermans D, Fioretti PM, Boersma E, Bax JJ, Thomson IR, Roelandt JR, et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. Circulation 1999; 99: 757-62.
19. Marwick TH, Case C, Sawada S, Rimmerman C, Brenneman P, Kovacs R, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol 2001; 37: 754-60.
20. Sicari R, Pasanisi E, Venneri L, Landi P, Cortigiani L, Picano E, Echo Persantine International Cooperative (EPIC) Study Group; Echo Dobutamine International Cooperative (EDIC) Study Group. Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol 2003; 41: 589-95.
21. Cortigiani L, Bigi R, Gigli G, Coletta C, Mariotti E, Dodi C, et al. Prognostic implications of intraventricular conduction defects in patients undergoing stress echocardiography for suspected coronary artery disease. Am J Med 2003; 115: 12-8.
22. Sicari R, Cortigiani L, Bigi R, Raciti M, Landi P, Picano E. Effects of medical therapy on the prognostic value of pharmacological stress echo. Circulation 2004; 109: 2116-23.
23. Pingitore A, Picano E, Varga A, Gigli G, Cortigiani L, Previtali M, et al. on behalf of the Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) study groups. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. J Am Coll Cardiol 1999; 34: 1769-1777.
24. Cortigiani L, Picano E, Landi P, Previtali M, Pirelli S, Bellotti P, et al. Value of pharmacological stress echocardigraphy in risk stratification of patients with single-vessel disease. A report from the echo-persantine and echo-dobutamine international cooperative studies. J Am Coll Cardiol 1998; 32: 69-74.
25. Pierard LA, De Landsheere CM, Berthe C, et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021-31.
26. Sicari R, Picano E, Landi P, Pingitore A, Bigi R, Coletta C, et al. on behalf of the Echo Dobutamine International Cooperative (EDIC) study: Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. J Am Coll Cardiol 1997; 29: 254-260.
27. Picano E, Sicari R, Landi P, Cortigiani L, Bigi R, Coletta C, et al. on behalf of the EDIC (Echo Dobutamine International Cooperative study) Group. The prognostic value of myocardial viability in medically treated patients with global fell ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation 1998; 99: 1078-1094.
28. Meluzin J, Cerny J, Frelich M, Stetka F, Spinarova L, Popelova J, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1998; 32: 912-920.
29. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39: 1151-8.
30. Sicari R, Ripoli A, Picano E, Borges AC, Varga A, Mathias W, et al. on behalf of the VIDA (Viability Identification with Dipyridamole Administration) study group. The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischemic left ventricular dysfunction. Eur Heart J 2001; 22: 837-844.
31. Sicari R, Picano E, Cortigiani L, Borges CA, Varga A, Palagi C, et al. on behalf of the VIDA (Viability Identification with Dobutamine Administration) Study Group. Prognostic value of myocardial viability recognized by low dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol 2003; 92: 1263-6.
32. Pratali L, Picano E, Otasevic P, Vigna C, Palinkas A, Cortigiani L, et al. Prognostic significance of dobutamine echocardiography in idiopathic dilated cardiomyopathy. Am J Cardiol 2001; 88: 1374-88.
33. Pratali L, Varga A, Sicari R, Santagata P, Palinkas A, Otasevic P, et al. Prognostic significance of contractile reserve during dipyiridamole stress echocardiography in idiopathic dilated cardiomyopathy. Eur Heart J 2003; 24:697 (abstract Suppl).
34. Picano E, Mathias W Jr, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, large scale, multicenter trial. Lancet 1994; 344: 1190-1192.
35. Picano E, Marini C, Pirelli S, Maffei S, Bolognese L, Chiriatti G, et al. Safety of intravenous high-dose dipyridamole echocardiography. The Echo-Persantine International Cooperative Study Group. Am J Cardiol 1992; 70: 252-8.
36. Lattanzi F, Picano E, Adamo E, Varga A. Dobutamine stress echocardiography: safety in diagnosing coronary artery disease. Drug Saf 2000; 22: 251-262.
37. Picano E, Alaimo A, Chubuchny V, Plonska E, Baldo V, Baldini U, et al. Noninvasive pacemaker stress echo for diagnosis of coronary artery disease: a multicenter study. J Am Coll Cardiol 2002; 40: 1305-1310.
38. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999; 99: 763-70.
39. Marwick TH. Stress echocardiography. Heart 2003; 89: 113-118.
40. Rigo F, Richieri M, Pasanisi E, Cutaia V, Zanella C, Delia Valentina P, et al. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol 2003; 91: 269-73.
41. Lowenstein J, Tiano C, Marquez G, Presti C, Quiroz C. Simultaneous analysis of wall motion and coronary flow reserve of the left anterior descending coronary artery by transthoracic doppler echocardiography during dipyridamole stress echocardiography. J Am See Echocardiogr 2003; 16: 607-13.
42. Nohtomi Y, Takeuchi M, Nagasawa K, Arimura K, Miyata K, Kuwata K, et al. Simultaneous assessment of wall motion and coronarv flow velocity in the left anterior descending coronary artery during dipyridamole stress echocardiography. J Am Soc Echocardiogr 2003; 16: 457-63.
43. Krzanowski M, Bozdon W, Dimitrow PP. Imaging of all three coronary arteries by transthoracic echocardiography - an illustrated guide. Cardiovascular Ultrasound 2003; 1: 16.
44. Glover DK, Ruiz M, Yang JY, Koplan BA, Allen TR, Smith WH, et al. Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist. Circulation 1996; 94: 1726-32.
45. Picano E. Stress echocardiography: a historical perspective. Special article. Am J Med 2003; 114: 126-30.
46. Picano E. Sustainability of medical imaging. Education and debate. BMJ 2004; 328: 578-580.
47. Andreka P, Nadhazi Z, Muzes G, Szantho G, Vandor L, Konya L, et al. Possible therapeutic targets in cardiac myocyte apoptosis. Curr Pharm Design 2004; 10(20): 2445-61.
48. Ferrari R, Guardigli G, Mele D, Percoco GF, Ceconi C, Curello S. Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm Design 2004; 10(14): 1699-711.
49. Rautureau Y, Baxter GF. Acute actions of natriuretic peptides in coronary vasculature and ischaemic myocardium. Curr Pharm Design 2004; 10(20): 2477-82.